Literature DB >> 2903059

Comparison of the central and peripheral effects of cetirizine and terfenadine.

J C Pechadre1, D Vernay, J F Trolese, M Bloom, P Dupont, J P Rihoux.   

Abstract

The peripheral and central effects of 10 mg cetirizine 2 HCl and 60 mg terfenadine have been compared with placebo in 9 healthy male volunteers. The peripheral effect, in terms of cutaneous reactivity to 1 microgram histamine i.d., was measured by planimetry of the wheal and erythemas. Central effects were assessed with a self-evaluation visual scale and from the results of electroencephalographic spectrum analysis. Peripheral inhibition of histamine reactivity was more intense and quicker for cetirizine than for terfenadine. On the self-evaluation scale, no significant difference between terfenadine, cetirizine and placebo was noted. The quantified EEG did not show any variation in spectral parameters at any time after cetirizine. By contrast, at 6 h terfenadine had increased slow waves and had inhibited the alpha band. Thus, 10 mg cetirizine 2 HCl had less effect on the central nervous system than terfenadine 60 mg, whilst its peripheral action appeared more quickly and was more intense.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903059     DOI: 10.1007/bf00558262

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  22 in total

1.  Comparative study of EEG effects of antihistamines in normal volunteers.

Authors:  L Goldstein; H B Murphree; C C Pfeiffer
Journal:  J Clin Pharmacol J New Drugs       Date:  1968 Jan-Feb

2.  Daytime sleepiness and antihistamines.

Authors:  T A Roehrs; E I Tietz; F J Zorick; T Roth
Journal:  Sleep       Date:  1984       Impact factor: 5.849

3.  Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo.

Authors:  R Fadel; N Herpin-Richard; J P Rihoux; E Henocq
Journal:  Clin Allergy       Date:  1987-07

4.  Peripheral antihistamine and central sedative effects of three H1-receptor antagonists.

Authors:  S Levander; O Hägermark; M Ståhle
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Effects of two antihistamine drugs on actual driving performance.

Authors:  T Betts; D Markman; S Debenham; D Mortiboy; T McKevitt
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-28

6.  Comparative study of the peripheral and central effects of terfenadine and cetirizine 2 HCl.

Authors:  J P Rihoux; P Dupont
Journal:  Ann Allergy       Date:  1987-09

7.  Antihistamines and sedation.

Authors:  A N Nicholson
Journal:  Lancet       Date:  1983-07-23       Impact factor: 79.321

8.  Pharmacokinetics and biotransformation studies of terfenadine in man.

Authors:  D A Garteiz; R H Hook; B J Walker; R A Okerholm
Journal:  Arzneimittelforschung       Date:  1982

9.  Receptor effects of cetirizine.

Authors:  S H Snyder; A M Snowman
Journal:  Ann Allergy       Date:  1987-12

10.  Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin.

Authors:  L Michel; C De Vos; J P Rihoux; C Burtin; J Benveniste; L Dubertret
Journal:  J Allergy Clin Immunol       Date:  1988-07       Impact factor: 10.793

View more
  8 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of H1-antihistamines.

Authors:  J P Desager; Y Horsmans
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

Review 2.  Terfenadine. The first nonsedating antihistamine.

Authors:  H C Masheter
Journal:  Clin Rev Allergy       Date:  1993

Review 3.  Cetirizine. An updated review of its pharmacological properties and therapeutic efficacy.

Authors:  J P Rihoux; S Mariz
Journal:  Clin Rev Allergy       Date:  1993

4.  Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study.

Authors:  Consuelo García-Gea; Maria Rosa Ballester; Juan Martínez; Rosa Maria Antonijoan; Esther Donado; Iñaki Izquierdo; Manuel-José Barbanoj
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

5.  Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers.

Authors:  A Patat; M C Perault; B Vandel; N Ulliac; I Zieleniuk; P Rosenzweig
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

Review 6.  Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria.

Authors:  D M Campoli-Richards; M M Buckley; A Fitton
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

7.  Lack of interaction between two antihistamines, mizolastine and cetirizine, and ethanol in psychomotor and driving performance in healthy subjects.

Authors:  A Patat; D Stubbs; C Dunmore; N Ulliac; B Sexton; I Zieleniuk; A Irving; W Jones
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 8.  H1-receptor antagonists. Comparative tolerability and safety.

Authors:  F E Simons
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.